-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WsleCRHvDXkbRvQM55vv2R2PkwhgFXJAiUdFw8IaYIHxnF0IlNnKOkK6zPbqR4gs LDmO2LaGNIotFax37wCAjA== 0000830158-04-000038.txt : 20040621 0000830158-04-000038.hdr.sgml : 20040621 20040621095810 ACCESSION NUMBER: 0000830158-04-000038 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040621 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20040621 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LABONE INC/ CENTRAL INDEX KEY: 0000830158 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 431039532 STATE OF INCORPORATION: MO FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-92137 FILM NUMBER: 04871767 BUSINESS ADDRESS: STREET 1: 10101 RENNER BLVD STREET 2: P. O. BOX 7568 CITY: LENEXA STATE: KS ZIP: 66219 BUSINESS PHONE: 9138881770 MAIL ADDRESS: STREET 1: 10101 RENNER BLVD STREET 2: X CITY: LENEXA STATE: KS ZIP: 66219 FORMER COMPANY: FORMER CONFORMED NAME: LAB HOLDINGS INC DATE OF NAME CHANGE: 19980406 FORMER COMPANY: FORMER CONFORMED NAME: SEAFIELD CAPITAL CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SEAFIELD CAPTIAL CORP DATE OF NAME CHANGE: 19910520 8-K 1 offer.htm LabOne, Inc. Form 8-K dated June 21, 2004

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report: June 21, 2004

Commission file number: 0-16946

LabOne, Inc.

10101 Renner Blvd.

Lenexa, Kansas 66219

(913) 888-1770

Incorporated in Missouri

I.R.S. Employer Identification Number: 43-1039532

 


Item 9.  Regulation FD Disclosure

LabOne Announces Proposed Offering of Convertible Senior Debentures

LabOne, Inc. (Nasdaq: LABS), announced today its intention to offer to qualified institutional buyers, pursuant to Rule 144A under the Securities Act of 1933, $90 million in aggregate principal amount of Convertible Senior Debentures due 2034. The Company also intends to grant the initial purchasers an option to purchase up to an additional $13.5 million principal amount of the debentures.

The debentures will be senior unsecured obligations of the Company and will be convertible, under certain circumstances, into a combination of cash and common stock of the Company. The debentures may not be redeemed by the Company prior to June 2009. Holders of the debentures may require the Company to repurchase some or all of the debentures in June 2011, 2014, and 2024 and upon certain specified corporate transactions.

The Company intends to use the net proceeds of the offering to reduce borrowings under its credit facility. The Company may in the future re-borrow a portion of these funds under its credit facility for the repurchase of shares of the Company's common stock. The closing of the sale of any debentures is subject to the Company's satisfaction with the final terms, including conversion premium and coupon rate.

This report on Form 8-K does not constitute an offer to sell or the solicitation of any offer to buy any securities. The offering will be made only to qualified institutional buyers in accordance with Rule 144A under the Securities Act of 1933. The securities to be offered have not been registered under the Securities Act, or any state securities laws, and unless so registered may not be offered or sold in the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state securities laws.

 

 


  

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 LabOne, Inc.

Date:  June 21, 2004

By /s/ John W. McCarty
John W. McCarty
Executive V.P. and Chief Financial Officer

-----END PRIVACY-ENHANCED MESSAGE-----